Benitec Biopharma Inc.
BNTC
NASDAQ·Healthcare·Biotechnology·Mkt cap $422.9M
$12.31
▲ +1.15%
P/E
-11.09
Mkt Cap
$422.9M
52-Wk Range
$9.85–$16.76
52-Week Range
$9.85 - $16.76
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 10.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary DNA-directed RNA interference (ddRNAi) platform with potential for improved durability
- Rare disease focus with less competitive landscapes and potential for expedited regulatory pathways
- Established intellectual property portfolio protecting core technology and therapeutic candidates
- Experienced management team with deep biotechnology and gene therapy expertise
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Clinical development progress of BB-301 for oculopharyngeal muscular dystrophy
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Strong
+16.4% over 3m
Quality
Loss-making
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying BNTC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 28, 2026
Most recent quarter reported revenue of $0. Reported EPS of -$0.26.
Reported EPS · last 4Q
Q2 25
-$0.26
Q1 25
-$0.22
Q4 25
-$0.39
Q3 25
-$0.24
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
$0
$0
$0
$0
$0
$556.0K
$0
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
4 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Wedbush · Jul 28, 2026
vs Industry
How BNTC stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related